2017 Skin Infections-API Market Insights - PowerPoint PPT Presentation

About This Presentation
Title:

2017 Skin Infections-API Market Insights

Description:

India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China. Complete report available at: – PowerPoint PPT presentation

Number of Views:26

less

Transcript and Presenter's Notes

Title: 2017 Skin Infections-API Market Insights


1
Skin Infections-API Insights, 2017
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_marketreportsonline.com
with your contact details and questions if any.
Published January 2017 Pages 60 Price US 1250
(Single User License)
2
Skin Infections-API Insights, 2017
The active pharmaceutical ingredients worldwide
market is in continuous development from the
recent years. There is expected to be a major
impact on the global API industry, with the large
number of blockbuster drugs going off patent in
the coming years. It is going to affect the
revenue of the API market as generic drugs occupy
the market. India and China produce a large perce
ntage of a majority of the APIs and intermediates
produced in the world currently. The USFDA and EMA
have strict guidelines for API manufacturing
'Process Validation General Principles and Practi
ces'. While countries such as Japan and Singapore
are signatories to the ICH Q7 regulation, India an
d China follow their national GMP guidelines. The
efficiency and expertise of Asian contract
manufacturers have positioned them in a very
strategic space in the global pharmaceutical
supply chain, with a vast majority of the APIs
and intermediates being sourced from markets such
as India and China. Skin Infections -API Insights
, 2017 Report describes the current therapeutics
that is propelling the pharmaceutical markets
worldwide. The report gives the clear idea on the
United States Drug Master File (USDMF) and Europe
DMF filed by worldwide countries related to
the Skin Infections. It also provides the India
and China API Manufactures who are driving the
current API Market. The report also highlights
the patent and patent exclusivity information.
The research analysis also presents the global
sales data till 2016. Buy Report _at_
http//www.marketreportsonline.com/contacts/purcha
se.php?name566868
3
Skin Infections-API Insights, 2017
  • Scope A snapshot of the global Market therape
    utics scenario for Skin Infections.
  • A review of the marketed products under
    prescription for Skin Infections, regulatory
    information and marketing status.
  • Coverage of global patent coverage and detailed
    commentaries on the US patent challenges.
  • Graphical representation of investigational
    products for patent expiry and market
    exclusivities across the globe.
  • Product profiles for marketed products for Skin
    Infections with complete description of mechanism
    of action, therapeutic class, target, route(s) of
    administration and chemical details.
  • Coverage of API Manufacturers for Skin Infections
    drugs in the United States, Europe and Asian
    Regions with location details.
  • Coverage of Regulatory filings in the US, Europe,
    and Asia specifically India and China for Skin
    Infections drugs.
  • Key discontinued Marketed products.
  • Global Sales Figure from 2012-2016.Reasons to Buy
  • Evaluate the marketing status and exclusivity
    details of Skin Infections key products to
    exploit opportunities for generic drug
    development opportunities.
  • Key players in the pharmaceutical industry.
  • Strategic drivers and restraints of this market
    are revealed and market opportunities and
    challenges are identified.
  • Design effective counter-strategies to gain
    competitive advantage by identifying the key
    patent expiry details and exclusivity with
    respect to Skin Infections.
  • API intelligence over marketed drugs for Skin
    Infections and gaining primary intelligence over
    active ingredients manufacturers across the
    globe.
  •  

4
Skin Infections-API Insights, 2017
  • Major Points from Table of Contents
  • Skin Infections Therapeutic Market, US, Marketed
    Drugs by Application Type, 2017
  • Skin Infections Therapeutic Market, US, Marketed
    Drugs by Marketing Status, 2017
  • Skin Infections Therapeutic Market, US, (Year),
    2017
  • Skin Infections Marketed Drugs, API Manufacturers
    by US DMF Status, 2017
  • Skin Infections Marketed Drugs, US DMF Status
    Drug Specific (Number), 2017
  • Skin Infections Therapeutic Market, Global Sales
    (in million USD), 2017
  • Skin Infections Marketed Drugs, API
    Manufacturers, Global, 2017
  • Discontinued Drugs for Skin Infections, 2017
  • For Fax Order Request Form Click Here

Buy Report _at_ http//www.marketreportsonline.com/c
ontacts/purchase.php?name566868
5
Skin Infections-API Insights, 2017
About Us MarketReportsOnline comprises of an
online library of 2,50,000 reports and in-depth
market research studies of over 5000 micro
markets. We provide 24/7 online and offline
support to our customers. Get in touch with us
for your needs of market research
reports. Contact Us Ritesh Tiwari 2nd Floor,
Metropole, Next to Inox Theatre, Bund Garden
Road, Pune, Maharashtra, India Tel 1 888 391
5441 E-mail sales_at_marketreportsonline.com
http//www.marketreportsonline.com/
Write a Comment
User Comments (0)
About PowerShow.com